Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Cancer Immunol Immunother

Search In Journal Title:

Abbravation: Cancer Immunology, Immunotherapy

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1016/0165-1781(90)90054-9

Search In DOI:

ISSN

1432-0851

Search In ISSN:
Search In Title Of Papers:

−509CgtT polymorphism in the TGFβ1 gene promote

Authors: Peng Qi Yueming Chen Hao Wang Meng Fang Qiang Ji Yunpeng Zhao Xiaojuan Sun Yan Liu Chunfang Gao
Publish Date: 2009/01/25
Volume: 58, Issue: 9, Pages: 1433-1440
PDF Link

Abstract

Hepatocellular carcinoma HCC is one of the most common malignant tumors worldwide The risk for developing HCC increases with severity of inflammation and fibrosis Transforming growth factorβ1 TGFβ1 is most frequently upregulated in tumor cells The most studied −509CT polymorphism of TGFβ1 gene has been associated with colorectal gynecologic and lung cancers To assess whether this polymorphism in TGFβ1 gene is associated with susceptibility to and/or clinicopathologic characteristics of HBVrelated HCC a total of 575 patients with chronic HBV infection and 299 healthy volunteers with no evidence of recent or remote HBV infection were prospectively enrolled The patients were divided into two groups those without n = 196 and those with HCC n = 379 These 379 HCC patients with chronic HBV infection were designated as cases the remaining 196 patients without HCC and 299 healthy volunteers served as disease and healthy controls respectively −509CT polymorphism in the TGFβ1 gene promoter was studied using restriction fragmentlength polymorphism In addition tumor tissues of liver n = 60 were obtained from the studied HCC patients for measurement of TGFβ1 mRNA expression levels We also assessed the plasma TGFβ1 levels of HBV patients without n = 94 or with HCC n = 136 and healthy subjects n = 120 In our study group the risk of HCC in Chinese patients with HBV infection was significantly lower with the TT genotypes than in those with the CC genotypes at position −509 of TGFβ1 gene P = 001 In addition in the case group patients with the CC genotype had a statistically significant higher median plasma TGFβ1 or liver tumor tissue TGFβ1 mRNA level compared with the individuals with the TT genotype However in a subsequent analysis of the association between this polymorphism and clinicopathological characteristics including tumor number size grade stage and invasiveness there was no significant difference in both the distribution of genotype or allelic frequency within HCC patients indicating that −509CT exchange in TGFβ1 gene may play an important role in the occurrence not the progression of HBVrelated HCC through influencing plasma concentrations of TGFβ1 or TGFβ1 mRNA expression of liver tumor tissue


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy
  2. Second International Symposium on Cancer Biology (ISCB), November 14–16, 2011, at the National Institute of Immunology, New Delhi, India
  3. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients
  4. Saccharomyces cerevisiae , the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice
  5. Higher numbers of T-bet + intratumoral lymphoid cells correlate with better survival in gastric cancer
  6. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E 2 results in high interleukin-12 production and cell migration
  7. Increase in CD14 + HLA-DR −/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
  8. CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells
  9. Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
  10. Epigenetic regulation of immune escape genes in cancer
  11. The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis
  12. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses
  13. Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle
  14. Bridging the innate and adaptive immune responses against cancer: 95th AACR meeting 2004
  15. Heterogeneity of CD8 + tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies
  16. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
  17. Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
  18. Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells
  19. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms
  20. H 2 O 2 production within tumor microenvironment inversely correlated with infiltration of CD56 dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction
  21. Lenalidomide enhances anti-myeloma cellular immunity
  22. Epidemiology: allergy history, IgE, and cancer
  23. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
  24. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
  25. Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
  26. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors
  27. Chordoma and chondrosarcoma gene profile: implications for immunotherapy
  28. Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
  29. Extracellular adenosine metabolism in immune cells in melanoma
  30. Collective action of hematopoietic cell subsets mediates anti-IL10R1 and CpG tumor immunity
  31. Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
  32. Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies
  33. Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function
  34. Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis

Search Result: